Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

The new class of weight-loss drugs are being tested as cure-alls for everything from knee replacements to liver disease and throwing corners of the stock market into disarray.

Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea StocksBitcoin Funds See Most Outflows Over Two Weeks Since ETF ApprovalChina Floats Perks for German Carmakers in Bid to Stop EV LeviesSri Lanka Set to Start Next Round of Investor Talks This WeekCitrus Exporter South Africa Asks WTO for Dispute Panels With EUNvidia enters correction territory as slump erases US$400 billionFrench Banks Still Solid Despite Election Selloff, Villeroy SaysHow listing a trusted contact could foil financial...

1 Billion PIK to Apex GroupRecord Labels Sue Two Startups for Training AI Models on Their SongsCar Sellers Warn Investors of Possible Financial Hit From CyberattackDeveloper of London’s World War II Tunnels to List in AmsterdamBitcoin Funds See Most Outflows Over Two Weeks Since ETF ApprovalChina Floats Perks for German Carmakers in Bid to Stop EV LeviesSri Lanka Set to Start Next Round of Investor Talks This WeekKuwait Finance House Explores Bid for Stake in Saudi Investment BankEU Sanctions...

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 83. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인